Why haven't biosimilars gained ground in the U.S.?

Two years after the first biosimilar approval in the U.S., biosimilars have yet to match sales forecasts. What is their path forward?

from Most popular articles from Medical Marketing and Media http://ift.tt/2zIpiJ8